Skip to main content
Top
Published in: BMC Urology 1/2016

Open Access 01-12-2016 | Research article

Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia

Authors: Rasa Ruseckaite, Fanny Sampurno, Jeremy Millar, Mark Frydenberg, Sue Evans

Published in: BMC Urology | Issue 1/2016

Login to get access

Abstract

Background

Men diagnosed with prostate cancer (PCa) in specific regional areas in Victoria, Australia have a poorer five-year survival rate compared to men living elsewhere in Victoria. This study aims to describe patterns-of- presentation and -care for men diagnosed with PCa in a specific regional Victorian area, and compare the outcomes with other Victorian regions.

Methods

Information on consecutive men diagnosed between 2008 and 2013 was extracted from the Prostate Cancer Outcomes Registry-Victoria. Descriptive analyses summarized diagnostic and treatment patterns of the 7,204 men with PCa in the selected region (n = 373), metropolitan Melbourne (n = 2,565) and remaining areas of Victoria (n = 4,266) to compare risk factors, treatments and time-taken-to-treatment.

Results

Men with PCa in the selected region were more likely to be diagnosed at older age (aged 68.6 vs 66 years in the rest of Victoria), and incidentally rather than through case-finding PSA blood tests. They were more likely to be presented with higher NCCN risk of the disease (High: 26 %, 24 % and 20.3 %; Very high/Metastasis: 11.8 %, 5.2 % and 5.7 % in the study region, metropolitan Melbourne and elsewhere in Victoria, respectively).
Men in the selected region were also more likely to have a longer time from diagnosis to treatment (on average 15–30 days longer when compared to the rest of Victoria).

Conclusions

Poorer outcomes of men with PCa in this specific region might be explained by multiple factors, including clinical-, patient-, and health-system-related. This range of explanatory factors, occurring at multiple points along the pathway of diagnosis and detection, suggests that interventions to improve outcomes for PCa in regional areas such as this need to be systematic. Interventions specifically addressing any one factor in isolation are unlikely to have much effect.
Literature
1.
2.
go back to reference Thomas AA, Pearce A, Sharp L, Gardiner RA, Chambers S, Aitken J, Molcho M, Baade P. Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks. Asia Pac J Clin Oncol. 2016. doi: 10.1111/ajco.12570. Thomas AA, Pearce A, Sharp L, Gardiner RA, Chambers S, Aitken J, Molcho M, Baade P. Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks. Asia Pac J Clin Oncol. 2016. doi: 10.​1111/​ajco.​12570.
3.
go back to reference Coory MD, Baade PD. Urban–rural differences in prostate cancer mortality, radical prostatectomy and prostate-specific antigen testing in Australia. Med J Aust. 2005;182(3):112–5.PubMed Coory MD, Baade PD. Urban–rural differences in prostate cancer mortality, radical prostatectomy and prostate-specific antigen testing in Australia. Med J Aust. 2005;182(3):112–5.PubMed
5.
6.
go back to reference Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, Rural–urban, and Racial Inequalities in US Cancer Mortality: Part I-All Cancers and Lung Cancer and Part II-Colorectal, Prostate, Breast, and Cervical Cancers. J Cancer Epidemiol. 2011;2011:107497. doi:10.1155/2011/107497.PubMed Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, Rural–urban, and Racial Inequalities in US Cancer Mortality: Part I-All Cancers and Lung Cancer and Part II-Colorectal, Prostate, Breast, and Cervical Cancers. J Cancer Epidemiol. 2011;2011:107497. doi:10.​1155/​2011/​107497.PubMed
8.
go back to reference Stamatiou K, Skolarikos A. Rural residence and prostate cancer screening with prostate-specific antigen. Rural Remote Health. 2009;9(2):1227.PubMed Stamatiou K, Skolarikos A. Rural residence and prostate cancer screening with prostate-specific antigen. Rural Remote Health. 2009;9(2):1227.PubMed
9.
go back to reference Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK. Urban–rural differences in prostate cancer outcomes in Australia: what has changed? Med J Aust. 2011;194(6):293–6.PubMed Baade PD, Youlden DR, Coory MD, Gardiner RA, Chambers SK. Urban–rural differences in prostate cancer outcomes in Australia: what has changed? Med J Aust. 2011;194(6):293–6.PubMed
11.
go back to reference ABS. Australian Bureau of Statistics. 2015. ABS. Australian Bureau of Statistics. 2015.
12.
go back to reference Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. Long-term Health-related Quality of Life After Primary Treatment for Localized Prostate Cancer: Results from the CaPSURE Registry. Eur Urol. 2014. doi:10.1016/j.eururo.2014.08.074. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR. Long-term Health-related Quality of Life After Primary Treatment for Localized Prostate Cancer: Results from the CaPSURE Registry. Eur Urol. 2014. doi:10.​1016/​j.​eururo.​2014.​08.​074.
13.
go back to reference Evans S, Millar J, Wood J, Davis I, Bolton D, Giles G, et al. The prostate cancer registry: monitoring paterns and quality of care for men diagnosed with prostate cancer. BJUI. 2012;111:e158–66.CrossRef Evans S, Millar J, Wood J, Davis I, Bolton D, Giles G, et al. The prostate cancer registry: monitoring paterns and quality of care for men diagnosed with prostate cancer. BJUI. 2012;111:e158–66.CrossRef
15.
go back to reference Rankin SL, Hughes-Anderson W, House AK, Heath DI, Aitken RJ, House J. Costs of accessing surgical specialists by rural and remote residents. ANZ J Surg. 2001;71(9):544–7.CrossRefPubMed Rankin SL, Hughes-Anderson W, House AK, Heath DI, Aitken RJ, House J. Costs of accessing surgical specialists by rural and remote residents. ANZ J Surg. 2001;71(9):544–7.CrossRefPubMed
16.
go back to reference Rao K, Manya K, Azad A, Lawrentschuk N, Bolton D, Davis ID, et al. Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre--impact on clinical decision-making and implications for patient inclusion. BJU Int. 2014;114 Suppl 1:50–4. doi:10.1111/bju.12764.CrossRefPubMed Rao K, Manya K, Azad A, Lawrentschuk N, Bolton D, Davis ID, et al. Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre--impact on clinical decision-making and implications for patient inclusion. BJU Int. 2014;114 Suppl 1:50–4. doi:10.​1111/​bju.​12764.CrossRefPubMed
17.
go back to reference Zigeuner R, Schips L, Lipsky K, Auprich M, Salfellner M, Rehak P, et al. Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology. 2003;62(5):883–7.CrossRefPubMed Zigeuner R, Schips L, Lipsky K, Auprich M, Salfellner M, Rehak P, et al. Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology. 2003;62(5):883–7.CrossRefPubMed
18.
19.
go back to reference Grivas N, Hastazeris K, Kafarakis V, Tsimaris I, Xousianitis Z, Makatsori A, et al. Prostate cancer epidemiology in a rural area of North Western Greece. Asian Pac J Cancer Prev. 2012;13(3):999–1002.CrossRefPubMed Grivas N, Hastazeris K, Kafarakis V, Tsimaris I, Xousianitis Z, Makatsori A, et al. Prostate cancer epidemiology in a rural area of North Western Greece. Asian Pac J Cancer Prev. 2012;13(3):999–1002.CrossRefPubMed
20.
go back to reference Obertova Z, Hodgson F, Scott-Jones J, Brown C, Lawrenson R. Rural–urban Differences in Prostate-Specific Antigen (PSA) Screening and Its Outcomes in New Zealand. J Rural Health. 2015. doi:10.1111/jrh.12127. Obertova Z, Hodgson F, Scott-Jones J, Brown C, Lawrenson R. Rural–urban Differences in Prostate-Specific Antigen (PSA) Screening and Its Outcomes in New Zealand. J Rural Health. 2015. doi:10.​1111/​jrh.​12127.
25.
go back to reference Fowler Jr FJ, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. Jama. 2000;283(24):3217–22.CrossRefPubMed Fowler Jr FJ, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. Jama. 2000;283(24):3217–22.CrossRefPubMed
26.
go back to reference Berg WT, Danzig MR, Pak JS, Korets R, RoyChoudhury A, Hruby G, et al. Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes. Prostate. 2015;75(10):1085–91. doi:10.1002/pros.22992.CrossRefPubMed Berg WT, Danzig MR, Pak JS, Korets R, RoyChoudhury A, Hruby G, et al. Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes. Prostate. 2015;75(10):1085–91. doi:10.​1002/​pros.​22992.CrossRefPubMed
27.
go back to reference McCombie SP, Hawks C, Emery JD, Hayne D. A 'One Stop' Prostate Clinic for rural and remote men: a report on the first 200 patients. BJU Int. 2015. doi:10.1111/bju.13100. McCombie SP, Hawks C, Emery JD, Hayne D. A 'One Stop' Prostate Clinic for rural and remote men: a report on the first 200 patients. BJU Int. 2015. doi:10.​1111/​bju.​13100.
29.
go back to reference Turrell G, Oldenburg BF, Harris E, Jolley DJ, Kimman ML. Socioeconomic disadvantage and use of general practitioners in rural and remote Australia. Med J Aust. 2003;179(6):325–6.PubMed Turrell G, Oldenburg BF, Harris E, Jolley DJ, Kimman ML. Socioeconomic disadvantage and use of general practitioners in rural and remote Australia. Med J Aust. 2003;179(6):325–6.PubMed
30.
go back to reference Obertova Z, Brown C, Holmes M, Lawrenson R. Prostate cancer incidence and mortality in rural men--a systematic review of the literature. Rural Remote Health. 2012;12(2):2039.PubMed Obertova Z, Brown C, Holmes M, Lawrenson R. Prostate cancer incidence and mortality in rural men--a systematic review of the literature. Rural Remote Health. 2012;12(2):2039.PubMed
31.
go back to reference Beard J, Tomaska N, Earnest A, Summerhayes R, Morgan G. Influence of socioeconomic and cultural factors on rural health. Austral J Rural Health. 2009;17(1):10–5.CrossRef Beard J, Tomaska N, Earnest A, Summerhayes R, Morgan G. Influence of socioeconomic and cultural factors on rural health. Austral J Rural Health. 2009;17(1):10–5.CrossRef
32.
go back to reference Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. AIHW: Canberra; 2007. Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. AIHW: Canberra; 2007.
33.
go back to reference Australian Institute of Health and Welfare. A snapshot of men’s health in regional and remote Australia. Canberra: AIHW2010 Contract No.: at. no. PHE 120. Australian Institute of Health and Welfare. A snapshot of men’s health in regional and remote Australia. Canberra: AIHW2010 Contract No.: at. no. PHE 120.
34.
go back to reference Carter S, Garside P, Black A. Multidisciplinary team working, clinical networks, and chambers; opportunities to work differently in the NHS. Qual Saf Health Care. 2003;12 Suppl 1:i25–8.CrossRefPubMedPubMedCentral Carter S, Garside P, Black A. Multidisciplinary team working, clinical networks, and chambers; opportunities to work differently in the NHS. Qual Saf Health Care. 2003;12 Suppl 1:i25–8.CrossRefPubMedPubMedCentral
Metadata
Title
Diagnostic and treatment factors associated with poor survival from prostate cancer are differentially distributed between regional and metropolitan Victoria, Australia
Authors
Rasa Ruseckaite
Fanny Sampurno
Jeremy Millar
Mark Frydenberg
Sue Evans
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2016
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-016-0172-4

Other articles of this Issue 1/2016

BMC Urology 1/2016 Go to the issue